ICD-10-CM Billable Code

R87.8

Other abnormal findings in specimens from female genital organs

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 Code R87.8 pertains to various abnormal findings identified in laboratory specimens taken from the female genital organs. This classification covers a range of irregularities that might be detected during diagnostic tests such as Pap smears, biopsies, or other laboratory assessments. Recognizing these findings is essential for guiding further medical evaluation and management, but it does not specify a particular diagnosis on its own. Healthcare providers interpret these abnormal results to determine the next steps in care.

Causes & Symptoms

Clinical Causes: Inflammatory processes or infections affecting the female genital tract, such as cervicitis or vaginitis. Presence of atypical or abnormal cells identified during cytology or biopsy, which may indicate pre-cancerous changes or other pathology. Benign conditions like polyps, cysts, or hyperplasia of the endometrial lining. Presence of foreign bodies or other foreign material detected in specimens. Sampling artifacts or technical issues during laboratory testing that result in abnormal findings. Other non-specific irregularities which do not fit into more specific diagnostic categories.

Key Symptoms: Often, abnormal findings are incidental results and do not cause noticeable symptoms. Possible symptoms if associated with underlying pathology include abnormal vaginal bleeding, unusual discharge, or pelvic discomfort. In cases where abnormal pathology is significant, symptoms may resemble those of infections or pre-cancerous conditions.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves the collection and examination of specimens from the female genital organs, which may include Pap smears, biopsies, or other laboratory tests. The laboratory reports may indicate abnormal findings that require further assessment. Additional diagnostic procedures, such as colposcopy, imaging studies, or repeated testing, can help clarify the significance of these findings. Ultimately, diagnosis depends on correlating laboratory results with clinical evaluation and additional testing as needed.

Treatment Protocols: Treatment depends on the specific abnormality identified and may involve watchful waiting, repeat testing, or further diagnostic procedures. If the findings suggest pre-cancerous or cancerous changes, treatment options could include surgical excision, laser therapy, or medical management. Similarly, infections or inflammations may require antibiotics or other targeted therapies. Ongoing monitoring and follow-up are often essential to ensuring appropriate management.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is R87.8 a billable ICD-10 code?
Yes, R87.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report R87.8?
Clinical documentation must specify the nature of Other abnormal findings in specimens from female genital organs and any associated comorbidities for accurate reporting.

Cite this Clinical Reference